sodium phosphate dibasic heptahydrate + sodium phosphate monobasic

**sodium phosphate dibasic heptahydrate + sodium phosphate monobasic** is a parenteral phosphate replacement product used to prevent or correct hypophosphatemia, particularly in patients with restricted or absent oral intake. It is marketed as **Sodium Phosphates Injection, USP, 3 mM P/mL** and contains sodium phosphate salts that provide elemental phosphorus for addition to large-volume intravenous fluids or compounded parenteral nutrition formulations. Mechanistically, it acts as an **electrolyte and phosphate replenisher**, restoring systemic phosphate needed for intracellular energy metabolism, including ATP generation, red blood cell glucose utilization, and other phosphorylation-dependent biological processes. The product is manufactured as a generic hospital injectable by companies including Pfizer, Fresenius Kabi, and Civica.

Brand names

Sodium Phosphates Injection

Other names

sodium phosphates injectionsodium phosphate dibasic heptahydrate + sodium phosphate monobasicmonobasic sodium phosphate monohydrate + dibasic sodium phosphate anhydroussodium phosphatesphosphorus replacement